2026 Benoît Van den Eynde: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	78	1740	1587	23	22	260	24519
Medicine	78	17976	16896	227	217	273	24578

Overview

Benoît Van den Eynde is affiliated with Ludwig Cancer Research in Belgium. Their research spans multiple areas within the biomedical sciences, focusing primarily on medicine, immunology, and molecular biology.

The main fields of study of Benoît Van den Eynde include:

Medicine
Immunology and Microbiology
Biochemistry, Genetics and Molecular Biology

Subfields of study feature a concentration in oncology and immunology, with additional work in molecular biology and biological psychiatry. Specific subfields include:

Oncology
Immunology
Molecular Biology
Biological Psychiatry
Psychiatry and Mental Health

The primary research topics covered in Van den Eynde's work focus on immune mechanisms and cancer therapies with detail on immune responses and cell function. Major topics include:

Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
Immune Cell Function and Interaction
CAR-T Cell Therapy Research
Tryptophan and Brain Disorders
Cancer, Stress, Anesthesia, and Immune Response
Ubiquitin and Proteasome Pathways

Recent publications illustrate the diversity and scope of Van den Eynde's research contributions. Selected recent papers include:

Preclinical murine tumor models: A structural and functional perspective, 2020, eLife
Tumour immune rejection triggered by activation of α2-adrenergic receptors, 2023, Nature
Systemic tryptophan homeostasis, 2022, Frontiers in Molecular Biosciences
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression, 2023, Journal for ImmunoTherapy of Cancer
Functional Differences between Proteasome Subtypes, 2022, Cells

Benoît Van den Eynde frequently collaborates with several co-authors, reflecting a network of scientific partnerships. Frequent co-authors include:

Jingjing Zhu
Stefan Naulaerts
Vincent Stroobant
Carol S. Leung
Nathalie Vigneron

The scientist's work is regularly published in journals emphasizing cancer immunotherapy and translational research. Frequent publication venues include:

Journal for ImmunoTherapy of Cancer
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Immunology Research
Zenodo (CERN European Organization for Nuclear Research)
Science Translational Medicine

Best Publications

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Catherine Uyttenhove;Luc Pilotte;Ivan Théate;Ivan Théate;Vincent Stroobant

2797
Citations
Tumor-antigens recognized by T-lymphocytes

Thierry Boon;Jean-Charles Cerottini;Benoît Van den Eynde;Pierre van der Bruggen

1644
Citations
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Pierre G. Coulie;Benoît J. Van den Eynde;Pierre van der Bruggen;Thierry Boon

1271
Citations
HUMAN T CELL RESPONSES AGAINST MELANOMA

Thierry Boon;Pierre G Coulie;Benoît J Van den Eynde;Pierre van der Bruggen

865
Citations
T cell defined tumor antigens

Benoît J Van den Eynde;Pierre van der Bruggen

809
Citations
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion.

Michael Platten;Wolfgang Wick;Benoît J. Van den Eynde;Benoît J. Van den Eynde

780
Citations
Tumor antigens recognized by T cells

Thierry Boon;Pierre G. Coulie;Benoît Van den Eynde

712
Citations
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Luc Pilotte;Pierre Larrieu;Vincent Stroobant;Didier Colau

645
Citations
Classification of current anticancer immunotherapies

Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

584
Citations
Tumor-specific shared antigenic peptides recognized by human T cells

Pierre van der Bruggen;Yi Zhang;Pascal Chaux;Vincent Stroobant

553
Citations
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

Sandra Morel;Frédéric Lévy;Odile Burlet-Schiltz;Francis Brasseur

521
Citations
An Antigenic Peptide Produced by Peptide Splicing in the Proteasome

Nathalie Vigneron;Vincent Stroobant;Jacques Chapiro;Annie Ooms

420
Citations
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

416
Citations
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues

Ivan Théate;Ivan Théate;Nicolas van Baren;Nicolas van Baren;Luc Pilotte;Luc Pilotte;Pierre Moulin

381
Citations
Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape

Abhishek D. Garg;Pierre G. Coulie;Benoit J. Van den Eynde;Patrizia Agostinis

306
Citations
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules

Benoît Guillaume;Jacques Chapiro;Vincent Stroobant;Didier Colau

305
Citations
Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

Benoı̂t J Van den Eynde;Sandra Morel

284
Citations
An antigen produced by splicing of noncontiguous peptides in the reverse order

Edus H. Warren;Edus H. Warren;Nathalie J. Vigneron;Nathalie J. Vigneron;Marc A. Gavin;Marc A. Gavin;Pierre G. Coulie

283
Citations
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.

Jingjing Zhu;Jingjing Zhu;Céline G. Powis de Tenbossche;Céline G. Powis de Tenbossche;Stefania Cané;Stefania Cané;Didier Colau;Didier Colau

259
Citations
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases

Véronique Corbière;Jacques Chapiro;Vincent Stroobant;Wenbin Ma

251
Citations
A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma.

Béatrice Gaugler;Nathalie Brouwenstijn;Valérie Vantomme;Jean-Pierre Szikora

250
Citations
Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Design, Synthesis and Preclinical Evaluation of a Novel TDO Inhibitor.

Eduard Dolušić;Pierre Larrieu;Laurence Moineaux;Vincent Stroobant

0
Citations

Frequent Co-Authors

Pierre van der Bruggen Université Catholique de Louvain

Thierry Boon Ludwig Cancer Research

Vincent Stroobant Ludwig Cancer Research

Pierre Coulie Université Catholique de Louvain

Johan Wouters University of Namur

Catherine Uyttenhove Ludwig Cancer Research

Francis Brasseur Ludwig Cancer Research

Catia Traversari MolMed (Italy)

Moreno Galleni University of Liège

Anne-Marie Schmitt-Verhulst Centre d’Immunologie de Marseille-Luminy

External Links

Personal website of Benoît Van den Eynde

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing degrees can open diverse career pathways in healthcare and research. Many students transition into specialized roles by enrolling in programs like the acute care certification for FNP, which enables nurse practitioners to provide advanced care for patients with complex conditions.

Faster degree options like the nurse practitioner accelerated program offer an efficient pathway to becoming a nurse practitioner, combining rigorous training with flexible online learning formats ideal for busy students or career changers.

For individuals without a nursing background, online ABSN programs for non nurses provide an accessible gateway into nursing. These accelerated programs streamline the path from a non-nursing degree to a nursing career, equipping graduates to contribute meaningfully in clinical and research immunology settings.

Additionally, those seeking less competitive options may find success with the easiest accelerated nursing programs to get into. These programs still maintain quality education and can serve as a stepping stone to advanced immunology-related roles.